| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |